Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Want to Work in Psychedelics? Here Are 10 Psychedelic Jobs to...

Natural Medicine Advisory Bulletin 13: Peaking in July

Natural Medicine Advisory Bulletin 13.5: The Birth of a Regulated Psychedelics...

Ancestral Teachings for the Psychedelic Renaissance

Build Your Career: Somatic Coaching and Holotropic Fitness

Buddhist Philosophy, Shadow Work, and Integrating a Psychedelic Experience

Breaking: Lykos Lays Off 75% of Staff, Ropes In Pharma Veteran,...

Pα+ Psychedelic Bulletin #170: Is MindMed Eyeing Depression? atai Approaches Phase...

“It Was Exactly What I Needed – Until I Was Arrested...

Rumination, the Default Mode Network, and How Neuroplasticity Changes Over Time

1...111213...218 Page 12 of 218

Colorado’s Psilocybin Supply Chain Complete: First Testing Lab Licensed, Sessions Could...

Pα+ Psychedelic Bulletin #196: Otsuka Eyes Psychedelic Future in Japan; First...

EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin